(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-CYCLOPENTYLENECYCLOPROPANECARBOXAMIDE
Compound with spectra: 1 NMR
![(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-CYCLOPENTYLENECYCLOPROPANECARBOXAMIDE](/api/compound/HS4X16lBLrU.png?ph=true&h=300&w=458 "(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-CYCLOPENTYLENECYCLOPROPANECARBOXAMIDE")
| SpectraBase Compound ID | HS4X16lBLrU |
|---|---|
| InChI | InChI=1S/C17H22N4O/c1-2-15(19-20-18)14-12-17(14,13-8-4-3-5-9-13)16(22)21-10-6-7-11-21/h3-5,8-9,14-15H,2,6-7,10-12H2,1H3/t14-,15-,17+/m0/s1 |
| InChIKey | URGSALUADURYOY-YQQAZPJKSA-N |
| Mol Weight | 298.39 g/mol |
| Molecular Formula | C17H22N4O |
| Exact Mass | 298.179361 g/mol |
| Enantiomer InChIKey | URGSALUADURYOY-INMHGKMJSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-DIBUTYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-DIPROPYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-(4-FLUOROPHENYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-(4-METHYLPHENYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-(3-FLUOROPHENYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
(1S,2R)-1-(3-METHYLPHENYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
(1S,2R)-1-(3-FLUOROPHENYL)-2-[(S)-1-HYDROXYPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
DIETHYL(2-HYDROXYETHYL)METHYLAMMONIUM IODIDE, 4,4-DIPHENYL-1-ISOPROPYL-5-OXO-3-PYRROLIDINEPROPIONATE
1-[3-(4,4-DIPHENYL-1-ISOPROPYL-5-OXO-3-PYRROLIDINYL)PROPIONYL]HEXAMETHYLENEIMINE
4,4-DIPHENYL-1-ISOPROPYL-5-OXO-3-PYRROLIDINEPROPIONIC ACID, 2-(DIMETHYLAMINO)ETHYL ESTER, HYDROCHLORIDE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of (1S,2R)-1-Phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) Derivatives Modified at the Carbamoyl Moiety As a New Class of NMDA Receptor Antagonists | Bioorganic & Medicinal Chemistry | 2002 |